Literature DB >> 17624937

Intrauterine growth restriction and risk for arterial hypertension: a causal relationship?

Ludwig Gortner1.   

Abstract

AIMS: Intrauterine growth restriction (IUGR) has been demonstrated to have serious consequences for health in adult age. These include an increased risk for metabolic syndrome, pulmonary and cardiovascular disorders. These disorders are in part secondary to the development of arterial hypertension, which has been demonstrated to be more frequent in individuals subjected to restricted intrauterine growth.
METHODS: A review on publications on pathogenesis and epidemiology of hypertension associated to IUGR.
RESULTS: Current concepts for this association include a reduced nephrogenesis and increased arterial stiffness, impaired sympathetic regulation and steroid metabolism secondary to IUGR. Early postnatal risk-modifying factors include among others catch-up growth leading to childhood overweight.
CONCLUSION: IUGR increases the risk of hypertension in adult life. Identifying relevant risk factors for arterial hypertension will be the basis for the development of preventive concepts to be applied for predisposed individuals.

Entities:  

Mesh:

Year:  2007        PMID: 17624937     DOI: 10.1515/JPM.2007.082

Source DB:  PubMed          Journal:  J Perinat Med        ISSN: 0300-5577            Impact factor:   1.901


  3 in total

1.  Impact of Birth Weight and Length on Primary Hypertension in Children.

Authors:  Aneta Weres; Joanna Baran; Ewelina Czenczek-Lewandowska; Justyna Leszczak; Artur Mazur
Journal:  Int J Environ Res Public Health       Date:  2019-11-22       Impact factor: 3.390

2.  Effect of Vitamin D Supplementation on the Fetal Growth Rate in Pregnancy Complicated by Fetal Growth Restriction.

Authors:  Karolina Jakubiec-Wisniewska; Hubert Huras; Magdalena Kolak
Journal:  Children (Basel)       Date:  2022-04-12

3.  Birth weight and blood pressure: 'J' shape or linear shape? Findings from a cross-sectional study in Hong Kong Chinese women.

Authors:  Yao Jie Xie; Suzanne C Ho; Zhao-Min Liu; Stanley Sai-Chuen Hui
Journal:  BMJ Open       Date:  2014-09-08       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.